Harnessing mucosal immunity against respiratory viruses using adenoviral vectors encoding cytokines/chemokines as mucosal adjuvants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2024
- Schlagwort
-
Immunreaktion
Virusimpfstoff
Impfstoff
Wirtszelle
Influenzaviren
Virusinfektion
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2024
- Urheber
- Beteiligte Personen und Organisationen
-
Tenbusch, Matthias
Anja, Lux
Winkler, Thomas
Nitschke, Lars
- DOI
-
10.25593/open-fau-408
- URN
-
urn:nbn:de:101:1-2024022304032583885850
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vieira Antão, Ana
- Tenbusch, Matthias
- Anja, Lux
- Winkler, Thomas
- Nitschke, Lars
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2024
Ähnliche Objekte (12)
Evaluation of IL-1\(\beta\) and IL-18 as genetic adjuvants in adenoviral immunizations against influenza A viruses
Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Treatment of allergic asthma by gene based immunizations that induce specific targeting of antigens toward dendritic cells
Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Eradication of measles: remaining challenges
Die Rolle der humanen Polyomaviren Merkelzell-Polyomavirus, humanes Polyomavirus 6 und 7, und Trichodysplasia-spinulosa-assoziiertes Polyomavirus in der Pathogenese kutaner B- und T-Zell-Lymphome
Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity
Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine
Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model
Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus
Evaluation of IL-1\(\beta\) and IL-18 as genetic adjuvants in adenoviral immunizations against influenza A viruses
Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Treatment of allergic asthma by gene based immunizations that induce specific targeting of antigens toward dendritic cells
Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Eradication of measles: remaining challenges
Die Rolle der humanen Polyomaviren Merkelzell-Polyomavirus, humanes Polyomavirus 6 und 7, und Trichodysplasia-spinulosa-assoziiertes Polyomavirus in der Pathogenese kutaner B- und T-Zell-Lymphome
Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity
Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine
Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model
Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus
Evaluation of IL-1\(\beta\) and IL-18 as genetic adjuvants in adenoviral immunizations against influenza A viruses
Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Treatment of allergic asthma by gene based immunizations that induce specific targeting of antigens toward dendritic cells
Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Eradication of measles: remaining challenges
Die Rolle der humanen Polyomaviren Merkelzell-Polyomavirus, humanes Polyomavirus 6 und 7, und Trichodysplasia-spinulosa-assoziiertes Polyomavirus in der Pathogenese kutaner B- und T-Zell-Lymphome
Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity
Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine
Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model